In this study, serum GDF-15 levels were measured in patients with PD, as well as in patients with PSP and MSA, to investigate the potential usefulness of serum GDF-15 levels as a biomarker in differential diagnosis. The gene discussed is GDF15; the disease is Parkinson disease.